Verónica González-Calle

Has grant

University Hospital of Salamanca

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Beca de Estancias de Investigación en un centro extranjero 2016.

Open Date: 2016-05-01

Close Date: 2017-05-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Felipe de Arriba de la Fuente

Profesor Asociado

Universidad de Murcia

SPAIN

View details

María-Victoria Mateos

University Hospital of Salamanca

SPAIN

View details

Wojciech Maciej Legiec

head physician

POLAND

View details

Roman Hajek

University of Ostrava

CZECH REPUBLIC

View details

Tomas Jelinek

CZECH REPUBLIC

View details

Lucia Lopez Corral

Universidad de Salamanca

SPAIN

View details

Enrique M. Ocio

SPAIN

View details

Albert Oriol

Institut Català d'Oncologia

SPAIN

View details

Lidia Usnarska-Zubkiewicz

Wroclaw Medical University

POLAND

View details

Norma C. Gutiérrez

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Verónica González-Calle

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Daratumumab: a game changer in early myeloma

Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience

Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma

Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.

Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high risk smoldering multiple myeloma included in the GEM-CESAR trial.

High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience.

Measurable residual disease by mass spectrometry and next-generation flow to assess treatment response in myeloma.

Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.

A research center's experience of T-cell-redirecting therapies in triple-class refractory multiple myeloma.

Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cells.

Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies

Lenalidomide maintenance based on a genetic profile

Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance–Like Phenotype in Patients With Monoclonal Gammopathies

Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma

Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma

Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors.

Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors

Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival.

Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival

Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma.

Collaborators (10)

Felipe de Arriba de la Fuente

María-Victoria Mateos

Wojciech Maciej Legiec

Roman Hajek

Tomas Jelinek

Lucia Lopez Corral

Enrique M. Ocio

Albert Oriol

Lidia Usnarska-Zubkiewicz

Norma C. Gutiérrez

Make your next move.